LifeSci‑IP is led by Brad Salcedo, an IP strategist with more than 30 years of experience guiding biologics, neuroscience, diagnostics, and medtech companies across the US, UK, EU, and UAE.
Brad has spent his career helping innovators turn IP into a commercial asset — strengthening valuation, reducing risk, and enabling partnerships that move science forward.
What founders value:
IP is not paperwork. It’s a strategic lever that shapes market exclusivity, valuation, and future dealmaking. When used well, it accelerates a company’s trajectory.
· Strengthen your valuation and reduce strategic risk. Schedule a brief conversation.
· Secondary CTA See how early IP decisions can shape your company’s future.
Let’s explore how your science can gain the protection and positioning it deserves.
Copyright © 2026 LifeSci IP - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.